Edwards Lifesciences Other current assets decreased by 2.9% to $329.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.2%, from $304.50M to $329.50M. Over 5 years (FY 2020 to FY 2025), Other current assets shows an upward trend with a 10.3% CAGR.
Significant fluctuations may indicate changes in prepaid operational costs or shifts in short-term working capital management.
This category aggregates miscellaneous current assets that do not fit into standard classifications like cash, inventory...
Commonly found in all industrial balance sheets; usually represents a small percentage of total current assets.
current_assets_other_assets_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $233.30M | $241.90M | $237.10M | $234.50M | $248.80M | $267.60M | $195.90M | $190.30M | $217.40M | $235.80M | $239.30M | $250.60M | $252.10M | $231.00M | $347.60M | $304.50M | $314.40M | $323.40M | $339.30M | $329.50M |
| QoQ Change | — | +3.7% | -2.0% | -1.1% | +6.1% | +7.6% | -26.8% | -2.9% | +14.2% | +8.5% | +1.5% | +4.7% | +0.6% | -8.4% | +50.5% | -12.4% | +3.3% | +2.9% | +4.9% | -2.9% |
| YoY Change | — | — | — | — | +6.6% | +10.6% | -17.4% | -18.8% | -12.6% | -11.9% | +22.2% | +31.7% | +16.0% | -2.0% | +45.3% | +21.5% | +24.7% | +40.0% | -2.4% | +8.2% |